טוען...
Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation
Background: The pharmacological cardioversion of recent-onset atrial fibrillation (AF) is a challenge for the clinician. The aim of the study was to compare the efficacy, the safety, and the overall cost of intravenous (iv) administration of vernakalant, which is a relatively new atrial-selective an...
שמור ב:
| הוצא לאור ב: | Hippokratia |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6239091/ https://ncbi.nlm.nih.gov/pubmed/30455558 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|